Metrizamide
VARIOUS
Also known as: amipaque, telebrix
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Metrizamide is an ofm drug catalogued in DrugCentral. It was first approved by the FDA in 1978.
- Approval status: ofm (first approved 1978 by the FDA).
- ATC code: V08AB01 (Watersoluble, nephrotropic, low osmolar X-ray contrast media).
- Molecular formula: C18H22I3N3O8; molecular weight 789.10 g/mol.
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1978-08-23 | FDA | — | — |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
V08AB01 | VARIOUS › CONTRAST MEDIA › X-RAY CONTRAST MEDIA, IODINATED › Watersoluble, nephrotropic, low osmolar X-ray contrast media |
Chemical structure
| Molecular formula | C18H22I3N3O8 |
|---|---|
| Molecular weight | 789.10 g/mol |
| CAS number | — |
| InChIKey | BAQCROVBDNBEEB-UBYUBLNFSA-N |
| PubChem CID | 443944 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
When was Metrizamide first approved?
Metrizamide was first approved by the FDA in 1978.
What is the chemical formula of Metrizamide?
Metrizamide has the molecular formula C18H22I3N3O8 and a molecular weight of 789.10 g/mol.
Browse: all drugs starting with M · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 1788 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL462394 — compound record and bioactivity
- PubChem CID 443944 — chemical identifiers
- DrugBank DB01578 — drug record
- FDA UNII RHH3W8F1CO — substance identity
- DailyMed: FDA labels for Metrizamide — current prescribing information (label search)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.